| Simplify-1: A phase III randomized trial of momelotinib versus ruxolitinib in janus kinase inhibitor–naïve patients with myelofibrosis RA Mesa, JJ Kiladjian, JV Catalano, T Devos, M Egyed, A Hellmann, ... Journal of Clinical Oncology 35 (34), 3844-3850, 2017 | 371 | 2017 |
| Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group NM Kröger, JH Deeg, E Olavarria, D Niederwieser, A Bacigalupo, ... Leukemia 29 (11), 2126-2133, 2015 | 345 | 2015 |
| Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells NR Mathew, F Baumgartner, L Braun, D O'Sullivan, S Thomas, ... Nature medicine 24 (3), 282-291, 2018 | 292 | 2018 |
| Applying synthetic lethality for the selective targeting of cancer DP McLornan, A List, GJ Mufti New England Journal of Medicine 371 (18), 1725-1735, 2014 | 291 | 2014 |
| Current and future status of JAK inhibitors DP McLornan, JE Pope, J Gotlib, CN Harrison The lancet 398 (10302), 803-816, 2021 | 234 | 2021 |
| Guideline for the investigation and management of eosinophilia N Butt, J Lambert, S Ali, P Beer, N Cross, A Duncombe, J Ewing, ... British journal of haematology 176 (4), 2017 | 191 | 2017 |
| Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis with prior exposure to Janus kinase 1/2 inhibitors M Shanavas, U Popat, LC Michaelis, V Fauble, D McLornan, R Klisovic, ... Biology of Blood and Marrow Transplantation 22 (3), 432-440, 2016 | 184 | 2016 |
| A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline M McMullin, C Harrison, S Ali, C Cargo, F Chen, J Ewing, M Garg, ... British journal of haematology 184 (2), 2018 | 172 | 2018 |
| Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning K Raj, A Pagliuca, K Bradstock, V Noriega, V Potter, M Streetly, ... Biology of Blood and Marrow Transplantation 20 (6), 890-895, 2014 | 161 | 2014 |
| Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment S Kordasti, B Costantini, T Seidl, P Perez Abellan, M Martinez Llordella, ... Blood, The Journal of the American Society of Hematology 128 (9), 1193-1205, 2016 | 149 | 2016 |
| Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia J Clay, AG Kulasekararaj, V Potter, F Grimaldi, D McLornan, K Raj, ... Biology of Blood and Marrow Transplantation 20 (11), 1711-1716, 2014 | 149 | 2014 |
| Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study S Verstovsek, AT Gerds, AM Vannucchi, HK Al-Ali, D Lavie, ... The Lancet 401 (10373), 269-280, 2023 | 148 | 2023 |
| Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative … JV Jovanovic, A Ivey, AM Vannucchi, E Lippert, E Oppliger Leibundgut, ... Leukemia 27 (10), 2032-2039, 2013 | 135 | 2013 |
| JAK2 V617F: a single mutation in the myeloproliferative group of disorders D McLornan, M Percy, MF McMullin The Ulster medical journal 75 (2), 112, 2006 | 114 | 2006 |
| A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology Guideline MFF McMullin, AJ Mead, S Ali, C Cargo, F Chen, J Ewing, M Garg, ... British journal of haematology 184 (2), 161, 2018 | 104 | 2018 |
| Myeloablative and reduced-intensity conditioned allogeneic hematopoietic stem cell transplantation in myelofibrosis: a retrospective study by the Chronic Malignancies Working … D McLornan, R Szydlo, L Koster, Y Chalandon, M Robin, C Wolschke, ... Biology of Blood and Marrow Transplantation 25 (11), 2167-2171, 2019 | 100 | 2019 |
| Immunological consequences of JAK inhibition: friend or foe? DP McLornan, AA Khan, CN Harrison Current hematologic malignancy reports 10, 370-379, 2015 | 100 | 2015 |
| JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells C Keohane, S Kordasti, T Seidl, P Perez Abellan, NSB Thomas, ... British journal of haematology 171 (1), 60-73, 2015 | 98 | 2015 |
| Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome E Bono, D McLornan, E Travaglino, S Gandhi, A Gallì, AA Khan, ... Leukemia 33 (10), 2495-2505, 2019 | 91 | 2019 |
| Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King's College Hospital M Wang, W Wang, A Abeywardane, M Adikarama, D McLornan, K Raj, ... Biology of Blood and Marrow Transplantation 21 (1), 60-66, 2015 | 90 | 2015 |
